Loading…

Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system

Pharmaceutical co-crystals are multicomponent molecular systems typically formed through hydrogen bonding of a co-former molecule with the active pharmaceutical ingredient (API). Just as many single component molecular structures can exhibit polymorphism due to the geometry of hydrogen bond donors a...

Full description

Saved in:
Bibliographic Details
Main Authors: Keddon Powell, Giulia Bartolini, Kate E. Wittering, Ali N. Saleemi, Chick C. Wilson, Chris Rielly, Zoltan Nagy
Format: Default Article
Published: 2015
Subjects:
Online Access:https://hdl.handle.net/2134/19099
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1818172599961649152
author Keddon Powell
Giulia Bartolini
Kate E. Wittering
Ali N. Saleemi
Chick C. Wilson
Chris Rielly
Zoltan Nagy
author_facet Keddon Powell
Giulia Bartolini
Kate E. Wittering
Ali N. Saleemi
Chick C. Wilson
Chris Rielly
Zoltan Nagy
author_sort Keddon Powell (1228920)
collection Figshare
description Pharmaceutical co-crystals are multicomponent molecular systems typically formed through hydrogen bonding of a co-former molecule with the active pharmaceutical ingredient (API). Just as many single component molecular structures can exhibit polymorphism due to the geometry of hydrogen bond donors and acceptors, the same is true for pharmaceutical co-crystals. In this study, the selective cocrystallization of the desired polymorphic form of urea-barbituric acid (UBA) co-crystals (forms I and III) is demonstrated, applying a novel periodic mixed suspension mixed product removal (PMSMPR) crystallizer cascade. The process was monitored using an integrated process analytical technology (PAT) array consisting of Raman spectroscopy, attenuated total reflectance ultraviolet/visible (ATRUV/ vis) spectroscopy, focused beam reflectance measurement (FBRM), particle vision microscopy (PVM), and an in-house developed commercial crystallization process informatics system (CryPRINS) software tool to determine when a “state of controlled operation” (SCO) was achieved. Three different start-up strategies were employed and their ability to produce selectively a particular polymorphic form of UBA was evaluated. The experimental conditions for producing pure UBA form I were optimized, but pure UBA form III remained elusive. Off-line characterization of the UBA polymorphs was carried out using Powder X-ray Diffraction (PXRD) and Raman spectroscopy.
format Default
Article
id rr-article-9241352
institution Loughborough University
publishDate 2015
record_format Figshare
spelling rr-article-92413522015-09-14T00:00:00Z Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system Keddon Powell (1228920) Giulia Bartolini (1515979) Kate E. Wittering (1354260) Ali N. Saleemi (1515976) Chick C. Wilson (1310187) Chris Rielly (1254369) Zoltan Nagy (1254105) Inorganic chemistry not elsewhere classified Chemical engineering not elsewhere classified untagged Chemical Engineering not elsewhere classified Inorganic Chemistry Pharmaceutical co-crystals are multicomponent molecular systems typically formed through hydrogen bonding of a co-former molecule with the active pharmaceutical ingredient (API). Just as many single component molecular structures can exhibit polymorphism due to the geometry of hydrogen bond donors and acceptors, the same is true for pharmaceutical co-crystals. In this study, the selective cocrystallization of the desired polymorphic form of urea-barbituric acid (UBA) co-crystals (forms I and III) is demonstrated, applying a novel periodic mixed suspension mixed product removal (PMSMPR) crystallizer cascade. The process was monitored using an integrated process analytical technology (PAT) array consisting of Raman spectroscopy, attenuated total reflectance ultraviolet/visible (ATRUV/ vis) spectroscopy, focused beam reflectance measurement (FBRM), particle vision microscopy (PVM), and an in-house developed commercial crystallization process informatics system (CryPRINS) software tool to determine when a “state of controlled operation” (SCO) was achieved. Three different start-up strategies were employed and their ability to produce selectively a particular polymorphic form of UBA was evaluated. The experimental conditions for producing pure UBA form I were optimized, but pure UBA form III remained elusive. Off-line characterization of the UBA polymorphs was carried out using Powder X-ray Diffraction (PXRD) and Raman spectroscopy. 2015-09-14T00:00:00Z Text Journal contribution 2134/19099 https://figshare.com/articles/journal_contribution/Toward_continuous_crystallization_of_Urea-Barbituric_acid_a_polymorphic_co-crystal_system/9241352 CC BY-NC-ND 4.0
spellingShingle Inorganic chemistry not elsewhere classified
Chemical engineering not elsewhere classified
untagged
Chemical Engineering not elsewhere classified
Inorganic Chemistry
Keddon Powell
Giulia Bartolini
Kate E. Wittering
Ali N. Saleemi
Chick C. Wilson
Chris Rielly
Zoltan Nagy
Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system
title Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system
title_full Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system
title_fullStr Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system
title_full_unstemmed Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system
title_short Toward continuous crystallization of Urea-Barbituric acid: a polymorphic co-crystal system
title_sort toward continuous crystallization of urea-barbituric acid: a polymorphic co-crystal system
topic Inorganic chemistry not elsewhere classified
Chemical engineering not elsewhere classified
untagged
Chemical Engineering not elsewhere classified
Inorganic Chemistry
url https://hdl.handle.net/2134/19099